B. Devapatla

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer

S. Woo, Ankur Sharma, B. Devapatla, 2015, PloS one.

Identification of signature genes associated with therapeutic resistance to anti-VEGF therapy

S. Woo, S. Dogra, B. Devapatla, 2020, Oncotarget.

Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strains.

J. Sanders, B. Devapatla, D. Samuelson, 2012, Cytokine.

The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein

K. Yaddanapudi, K. Davis, B. Devapatla, 2014, Oncotarget.

Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis

R. Janknecht, Resham Bhattacharya, K. Ding, 2019, Molecular Cancer Research.

Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.

K. Yaddanapudi, K. Davis, B. Devapatla, 2016, F1000Research.

Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin

K. Yaddanapudi, K. Davis, B. Devapatla, 2016, F1000Research.